Medistim ASA (OSL:MEDI)

Medistim ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,751	2,738	3,912	4,216	6,693	4,550
Market Cap Growth	53.96%	-30.01%	-7.22%	-37.01%	47.10%	30.29%
Enterprise Value	4,615	2,618	3,790	4,111	6,629	4,475
Last Close Price	260.00	144.18	201.40	214.03	335.63	225.71
PE Ratio	33.38	26.37	37.68	36.99	73.64	65.58
Forward PE	30.67	25.34	33.80	39.94	61.56	55.62
PS Ratio	7.17	4.92	7.51	8.67	16.02	12.77
PB Ratio	11.35	6.27	9.83	11.47	21.87	17.72
P/TBV Ratio	14.02	7.26	11.10	12.71	24.26	20.30
P/FCF Ratio	25.69	19.98	38.05	40.45	55.79	68.24
P/OCF Ratio	24.87	19.13	32.82	37.15	52.55	61.38
EV/Sales Ratio	6.97	4.71	7.27	8.45	15.87	12.56
EV/EBITDA Ratio	22.80	17.84	25.83	26.11	52.09	42.60
EV/EBIT Ratio	25.68	19.97	28.83	29.10	59.73	46.87
EV/FCF Ratio	24.95	19.11	36.86	39.43	55.26	67.11
Debt / Equity Ratio	0.05	0.08	0.04	0.05	0.08	0.15
Debt / EBITDA Ratio	0.10	0.22	0.11	0.10	0.18	0.35
Debt / FCF Ratio	0.12	0.25	0.17	0.16	0.20	0.59
Asset Turnover	1.24	1.03	1.05	1.10	1.12	1.05
Inventory Turnover	0.77	0.74	0.87	1.01	0.93	0.76
Quick Ratio	2.03	2.41	2.53	2.64	2.62	2.23
Current Ratio	3.33	4.00	4.15	3.87	3.95	4.13
Return on Equity (ROE)	34.58%	24.88%	27.12%	33.83%	32.30%	28.11%
Return on Assets (ROA)	21.07%	15.16%	16.62%	19.93%	18.52%	17.50%
Return on Capital (ROIC)	26.35%	18.48%	20.53%	24.69%	22.16%	20.97%
Return on Capital Employed (ROCE)	40.20%	28.00%	31.90%	36.90%	34.10%	33.30%
Earnings Yield	3.00%	3.79%	2.65%	2.70%	1.36%	1.52%
FCF Yield	3.89%	5.00%	2.63%	2.47%	1.79%	1.47%
Dividend Yield	2.31%	4.16%	2.23%	2.10%	1.12%	1.33%
Payout Ratio	76.86%	79.37%	79.15%	60.01%	60.11%	72.14%
Buyback Yield / Dilution	-	-0.10%	-0.10%	-0.15%	-0.07%	-0.13%
Total Shareholder Return	2.31%	4.06%	2.13%	1.95%	1.05%	1.20%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.